Welcome to our dedicated page for Regional Health SEC filings (Ticker: RHE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Regional Health Properties Inc. filings document material events for a self-managed healthcare real estate investment company with senior living and long-term care property exposure. Its 8-K disclosures cover material agreements, shareholder voting matters, capital-structure changes, governance actions, operating and financial results, and regulatory matters tied to its public-company status.
The filing record is centered on the company's common stock and preferred-share structure, including disclosures related to Series A and Series B preferred shares, agreements affecting securities or financing arrangements, and formal reports of corporate actions. These filings also document board and shareholder matters that affect the company's governance and financing profile.
Form 8-K (Item 8.01) filed 24 Jul 2025 by Regional Health Properties (RHE) merely announces the public posting of an investor presentation and a shareholder letter (Exhibits 99.1 & 99.2). Both documents relate to the pending all-stock merger with SunLink Health Systems; the joint proxy statement/prospectus (Form S-4, File No. 333-286975) was mailed on 30 Jun 2025 and a Schedule TO for a tender offer was filed on 18 Jul 2025.
Context & risks: The company reminds investors that its common and Series A preferred shares were delisted from NYSE American on 11 Jun 2025 and now trade on the OTCQB (tickers RHEP, RHEPA). No financial results or guidance are provided. Extensive forward-looking language restates integration, regulatory, liquidity and leverage risks that could derail or diminish anticipated merger synergies. Apart from furnishing additional disclosure materials, the filing makes no new commitments, and it expressly disclaims constituting an offer to sell securities.
Regional Health Properties has received a Notice of Effectiveness from the SEC for their Form S-4 registration statement, effective as of June 25, 2025, at 4:00 P.M. The Form S-4 (File Number: 333-286975) indicates a significant corporate action, typically involving:
- A potential merger, acquisition, or business combination
- Exchange offer of securities
- Corporate restructuring
This effectiveness notice means the SEC has completed its review and the registration statement is now active, allowing the company to proceed with their planned transaction. Investors should review the full S-4 filing for detailed information about the proposed corporate action and its potential impact on their investment.
Brent Morrison, CEO, President and Director of Regional Health Properties (NYSE: RHE), reported significant insider transactions on June 20, 2025:
- Exercised two stock options: - 24,000 shares at $3.32 per share - 24,000 shares at $2.03 per share
- Received a grant of 65,000 restricted shares as 2023 bonus compensation, vesting in equal installments on June 20, 2026 and 2027
- Following these transactions, Morrison now beneficially owns: - 198,047 shares directly - 2,272 shares indirectly through an IRA
The exercised options included a fully vested grant from January 2023 and another grant from January 2024 that completed vesting in January 2025. This significant increase in direct ownership demonstrates long-term commitment from the company's chief executive.
Regional Health Properties (RHE) and SunLink Health Systems have amended their Merger Agreement, extending the termination deadline from June 30, 2025, to August 11, 2025, 5:00 PM ET. This extension comes as both companies acknowledge that required shareholder approvals have not been obtained and are unlikely to be secured by the original deadline.
Key developments include:
- NYSE American filed Form 25 on June 11, 2025, to delist Regional's common stock and Series A Preferred Stock
- Both securities now trade on OTCQB under symbols "RHEP" and "RHEPA"
- Regional will file an S-4 Registration Statement including a joint proxy statement/prospectus for the proposed merger
The merger remains subject to several risks, including integration challenges, potential revenue synergy shortfalls, regulatory approvals, and shareholder approvals. The company cautions investors about forward-looking statements and urges review of the forthcoming joint proxy statement/prospectus for complete merger details.